Eli Lilly and Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| NOVO B | Novo Nordisk A/S | Outperform |
12
|
kr850.60 | kr696.07 | 12.86% | 14 | kr3.78T |
| MRK | Merck | Outperform |
2
|
$127.51 | $130.51 | 12.15% | 11 | $322.99B |
| AZN | AstraZeneca PLC | Outperform |
17
|
£120.50 | £165.99 | 35.23% | 16 | £186.80B |
| TMO | Thermo Fisher Scientific | Outperform |
10
|
$572.38 | $591.94 | 8.32% | 1 | $218.49B |
| NOVN | Novartis | Hold |
10
|
CHF87.97 | CHF105.00 | 22.34% | 9 | CHF179.49B |
| ROG | Roche Holding | Hold |
16
|
CHF217.30 | CHF307.83 | 25.40% | 9 | CHF175.19B |
| ABT | Abbott Laboratories | Outperform |
9
|
$105.90 | $118.92 | 18.04% | 7 | $184.23B |
| AMGN | Amgen | Outperform |
4
|
$311.29 | $303.65 | 2.80% | 8 | $166.97B |
| PFE | Pfizer | Outperform |
2
|
$27.81 | $32.87 | 9.67% | 6 | $157.48B |
| SAN | Sanofi | Outperform |
16
|
91.30€ | 102.80€ | 19.39% | 9 | 114.00€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$43.99 | $58.15 | 22.76% | 10 | $89.17B |
| GSK | GSK | Outperform |
12
|
£17.34 | £17.30 | 12.46% | 12 | £70.69B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$64.78 | $87.82 | 23.49% | 14 | $80.78B |
| ZTS | Zoetis | Outperform |
18
|
$167.07 | $220.47 | 32.58% | 5 | $76.23B |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥5.09k | ¥4.92k | 20.73% | 0 | ¥8.38T |
| MRNA | Moderna | Outperform |
16
|
$125.00 | $135.42 | 1.12% | 1 | $47.90B |
| SUNPHARMA | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.51k | Rp1.52k | 4.89% | 25 | Rp3.63T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | ¥4.74k | 10.30% | 0 | ¥6.47T |
| BAYN | Bayer | Hold |
5
|
28.02€ | 45.15€ | 7.07% | 4 | 27.53€B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$152.33 | $245.24 | 42.78% | 7 | $19.27B |
| BGNE | BeiGene | Buy |
6
|
$162.25 | $285.19 | 69.49% | 2 | $16.96B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$13.98 | $11.59 | 14.45% | 9 | $15.83B |
| DGX | Quest Diagnostics | Outperform |
10
|
$137.38 | $141.17 | 5.55% | 8 | $15.26B |
| 4507 | Shionogi & | Outperform |
18
|
¥7.34k | ¥7.12k | 8.93% | 0 | ¥2.09T |
| BIM | bioMérieux | Outperform |
18
|
98.70€ | 105.55€ | 15.50% | 1 | 11.82€B |
| FME | Fresenius Medical Care AG & Co... | Hold |
18
|
39.26€ | 41.13€ | -1.94% | 12 | 11.62€B |
| 4523 | Eisai | Outperform |
18
|
¥6.55k | ¥9.58k | 28.34% | 0 | ¥1.86T |
| IPN | Ipsen | Outperform |
17
|
114.50€ | 127.95€ | 4.80% | 0 | 9.42€B |
| ITCI | Intra-Cellular Therapies | Outperform |
10
|
$68.80 | $79.10 | 31.54% | 10 | $7.26B |
| 4528 | Ono Pharmaceutical | Hold |
18
|
¥2.31k | ¥2.76k | 8.44% | 0 | ¥1.07T |
| BPMC | Blueprint Medicines | Outperform |
6
|
$107.19 | $85.71 | 11.48% | 5 | $6.71B |
| EXEL | Exelixis | Outperform |
16
|
$21.90 | $26.44 | 23.29% | 5 | $6.44B |
| ZEAL | Zealand Pharma A/S | Outperform |
8
|
kr622.50 | kr357.00 | 30.92% | 2 | kr39.42B |
| HALO | Halozyme Therapeutics | Outperform |
11
|
$39.91 | $47.50 | 22.78% | 3 | $4.84B |
| HLUN A | H. Lundbeck A/S | Outperform |
18
|
kr33.50 | kr190.00 | 8.96% | 6 | kr32.86B |
| ALKS | Alkermes | Outperform |
10
|
$24.05 | $33.27 | 33.06% | 3 | $4.06B |
| NNI | Nelnet | Hold |
12
|
$96.57 | $95.00 | -6.80% | 1 | $3.47B |
| BHC | Bausch Health Companies | Hold |
15
|
$7.82 | $9.50 | 21.48% | 5 | $3.21B |
| VIRP | Virbac | Outperform |
18
|
355.50€ | 348.34€ | 3.80% | 5 | 2.90€B |
| 300529 | Jafron Biomedical | Buy |
18
|
¥27.54 | ¥26.62 | 12.38% | 0 | ¥21.33B |
| 4506 | Sumitomo Pharma | Underperform |
18
|
¥464.00 | ¥0.00 | 5.82% | 0 | ¥396.90B |
| INDV | Indivior PLC | Buy |
14
|
£14.35 | £28.89 | 115.54% | 4 | £1.95B |
| PFIZER | Pfizer | Outperform |
18
|
Rp4.21k | Rp4.53k | 17.20% | 3 | Rp194.76B |
| AMPH | Amphastar Pharmaceuticals | Outperform |
14
|
$42.46 | $69.00 | 46.02% | 0 | $2.02B |
| VETO | Vetoquinol | Hold |
18
|
94.60€ | 106.50€ | 14.16% | 0 | 1.12€B |
| OPK | OPKO Health | Outperform |
8
|
$1.01 | $6.70 | 296.04% | 0 | $1.18B |
| HIMX | Himax Technologies | Outperform |
13
|
$5.16 | $7.00 | 20.16% | 1 | $882.36M |
| 524735 | Hikal | Buy |
18
|
Rp297.45 | Rp328.00 | 10.94% | 1 | Rp37.41B |
| AMRN | Amarin | Underperform |
8
|
$0.91 | $2.05 | 9.89% | 1 | $378.19M |
| VNDA | Vanda Pharmaceuticals | Outperform |
0
|
$4.88 | $4.25 | 6.76% | 0 | $284.01M |
| OOMA | Ooma | Buy |
9
|
$7.23 | $18.60 | 104.01% | 4 | $255.16M |
| XERS | Xeris Biopharma Holdings | Buy |
6
|
$1.89 | $4.60 | 151.32% | 1 | $244.39M |
| PBYI | Puma Biotechnology | Hold |
10
|
$4.86 | $4.67 | -17.70% | 2 | $239.26M |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.27 | $10.86 | 252.42% | 3 | $222.46M |
| EDT | Spectral Medical | Buy |
0
|
C$0.43 | C$1.60 | 318.60% | 0 | C$167.15M |
| BIOC | GlaxoSmithKline S.A.E | - |
14
|
£31.08 | £0.00 | -100.00% | 0 | £3.30B |
| CODA | Coda Octopus Group | Buy |
0
|
$5.69 | $8.00 | 75.75% | 0 | $66.93M |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.17 | $0.65 | 488.24% | 0 | $56.27M |
| CTSO | Cytosorbents | Outperform |
11
|
$0.88 | $4.50 | 240.91% | 1 | $47.79M |
| PMN | ProMIS Neurosciences | Buy |
6
|
$1.96 | $18.49 | 513.27% | 0 | $37.20M |
| ECOR | electroCore | Buy |
0
|
$6.33 | $22.75 | 318.64% | 1 | $33.91M |
| POXEL | Poxel | - |
9
|
0.65€ | 3.50€ | -100.00% | 0 | 25.34€M |
| ACST | Acasti Pharma | Buy |
0
|
$2.96 | $16.34 | 172.30% | 0 | $26.98M |
| ORGS | Orgenesis | - |
6
|
$0.28 | $9.00 | -46.43% | 0 | $16.26M |
| LXXG.Q | LexaGene Holdings | - |
4
|
$0.11 | $0.75 | -100.00% | 0 | $11.34M |
| 542934 | Chandra Bhagat Pharma | - |
0
|
Rp114.85 | Rp0.00 | -100.00% | 0 | Rp866.55M |
| ULGX | Urologix | - |
0
|
$0.00 | $1.50 | 0.00% | 0 | $0.00M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |